CLINICAL_TRIALS trial_result · 2024-01-10

Clinical Trial Update: SAFIR02_Lung - Efficacy of Targeted Drugs Guided by Genomic Profiles in Metastatic NSCLC Patients [Phase 2]

Phase 2 clinical trial update evaluating targeted drugs guided by genomic profiles in metastatic non-small cell lung cancer (NSCLC).

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: UNICANCER | Conditions: Non-small Cell Lung Cancer Metastatic | Phase 2 | Status: COMPLETED